SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 216 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,158,768 | -23.5% | 110,400 | 0.0% | 5.39% | +34.3% |
| Q1 2024 | $5,433,888 | +4.3% | 110,400 | -22.7% | 4.02% | -7.0% |
| Q4 2023 | $5,212,200 | +14.0% | 142,800 | -27.8% | 4.32% | -17.6% |
| Q3 2023 | $4,570,824 | -11.8% | 197,700 | 0.0% | 5.24% | -23.5% |
| Q2 2023 | $5,183,694 | +1.9% | 197,700 | 0.0% | 6.85% | +19.0% |
| Q1 2023 | $5,088,798 | +78.0% | 197,700 | +79.9% | 5.75% | +111.2% |
| Q4 2022 | $2,858,499 | – | 109,900 | – | 2.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $429,009,000 | 24.30% |
| Consonance Capital Management LP | 1,201,399 | $88,387,000 | 9.42% |
| Boxer Capital, LLC | 2,075,905 | $152,724,000 | 5.18% |
| Perceptive Advisors | 4,849,912 | $356,808,000 | 4.51% |
| Orbimed Advisors | 6,186,307 | $455,127,000 | 4.26% |
| Samsara BioCapital, LLC | 169,852 | $12,496,000 | 2.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,262,075 | $92,851,000 | 1.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $41,094,000 | 0.86% |
| SPHERA FUNDS MANAGEMENT LTD. | 137,672 | $10,129,000 | 0.78% |
| Affinity Asset Advisors, LLC | 27,000 | $1,986,000 | 0.67% |